Yervoy
Quiénes somos
Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Resected MMR-p Colorectal and Pancreatic Cancer
Regorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metastatic Colorectal Cancer
Adoptive Cell Therapy Across Cancer Diagnoses
Interleucina-15 recombinante en combinación con los inhibidores de puntos de control nivolumab e ipilimumab en pacientes con cáncer refractario
Nivolumab e Ipilimumab y radioterapia en cáncer colorrectal y de páncreas con MSS y MSI alto
Ipilimumab, Maraviroc and Nivolumab (LUMINESCENCE)
Study of Tilsotolimod in Combination With Nivolumab and Ipilimumab for the Treatment of Solid Tumors (ILLUMINATE-206)
Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer
